Date: 20 September 2023 Universal PFAS Restriction and Sorafenib Possible Consequences of a PFAS REACH restriction on medicinal products - Sorafenib as one example out of many potentially impacted active pharmaceutical ingredients (API) Background Five national competent authorities (Germany, the Netherlands, Norway, Sweden and Denmark) have submitted an annex XV dossier under EU REACH on the restriction of per- and polyfluoroalkyl substances (PFAS) in January 2023 to ECHA.

Statement on the PFAS ban of selected koMatBatt project partners PFAS (perfluorinated and polyfluorinated substances) are currently indispensable as a class of materials from the point of view of energy storage.

PFAS restriction proposal Statement from SEW-EURODRIVE SEW-EURODRIVE GmbH & Co KG 1.

Exempted fluoroplastics and fluororubbers for use in fluid power equipment The European Union proposal to ban around 10,000 PFAS industrial chemicals would have a massively negative effect on the European fluid power industry and its customers if implemented in the form published on 22nd March 2023.

Remarks 4/26/2024 Universal PFAS restriction Overall Timeline and Important Milestones ECHA FFF restriction Scope Scope defined for RoI (exclusion WP2 and possible E-use WP7) Scope defined for Annex XV report (ongoing assessments can still lead to changes in scope i.e. substances/substance groups to be excluded, uses to be derogated etc.) 2nd round CfE Call for Evidence for specific information (15.

Date: 25-03-2020 Overall Timeline for PFAS-restriction process Pre-phase 2020 Milestones Timeline Coordination, alignment of approach and definition of work packages between DE, DK, NL, SE and NO CA as well as ECHA 27.

General Comments for Annex XV restriction report on Per- and polyfluoroalkyl substances (PFAS) 22 May 2023 We welcome the opportunity to contribute to the public consultation initiated by the European Chemicals Agency regarding potential restriction of Per- and polyfluoroalkyl substances (PFAS) according to Regulation (EC) No. 1907/2006 ("REACH").

General comments Aalberts Surface Technologies uses PFAS and especially fluoropolymers as ingredients and components of different types of thin films.

General Comments for Annex XV restriction report on Per- and polyfluoroalkyl substances (PFAS) 22 May 2023 We welcome the opportunity to contribute to the public consultation initiated by the European Chemicals Agency regarding potential restriction of Per- and polyfluoroalkyl substances (PFAS) according to Regulation (EC) No. 1907/2006 ("REACH").

scits swiss quality testing services Industrielack AG Herr Paul Englert Hmmerli 1 8855 Wangen CH-8953 Dietikon Grnaustrasse 23 10 00 www.sqts.ch CH-1784 Courtepin Rte de I'industrie 61 T-1111 Msqts.ch 909O-/ Prfbericht Berichtsdatum Auftragstyp Auftraggeber Einsender Bericht 2023L02603 / 1 2023L02603 / 1 30.

Comment on Proposed Restriction of PFAS Jul 31, 2023 Japan Valve Manufacturers' Association (JVMA) Japan Valve Manufacturers Association (JVMA) appreciates the opportunity to provide comments to the PFAS restriction proposal. 1.

2225 W.

Substance: Per- and polyfluoroalkyl substances (PFAS) EC number: CAS number: - Annex XV report Third Party Consultation From 22/03/2023 to 25/09/2023 General comments and answers to specific information requests Specific information requests: 1.

Application for exemption from EU REACHPFAS control for soluble polytetrafluoroethylene Subject: Application for permanent exemption of soluble polytetrafluoroethylene Basis: First, soluble polytetrafluoroethylene has excellent chemical stability, physical and mechanical properties, electrical insulation, lubricity, non-viscosity, aging resistance, nonflammability and thermal stability.

Antwerp, August 22nd 2022 Dear Worldwide about 140 million people are wearing contact lenses as an alternative to spectacles.